Literature DB >> 495653

Distal 2q duplication: report of two familial cases and an attempt to define a syndrome.

M Zankl, G Schwanitz, P Schmid, H Zankl, G Dockter, A Rodewald, K D Zang, K P Grosse.   

Abstract

Two cases of partial trisomy 2q are described, both resulting from a balanced translocation in one of the parents. In one case the chromosomes 2 and 11 were involved [paternal karyotype: 46,XY,t(2;11)(q33;q23)]; in the second case, chromosomes 2 and 8 [paternal karyotype: 46,XY, t(2;8(q32;p23)]. When the two patients were compared to the few cases reported in the literature, it was concluded that the associated clinical syndrome is characterized by severe psychomotor retardation and relatively mild abnormalities involving skull and facies.

Entities:  

Mesh:

Year:  1979        PMID: 495653     DOI: 10.1002/ajmg.1320040103

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  5 in total

1.  Abnormal chromosome complement resulting from a familial inversion of chromosome 2.

Authors:  S Richter; B Lockwood; D Lockwood; J Allanson
Journal:  J Med Genet       Date:  1989-11       Impact factor: 6.318

2.  Probable assignment of soluble isocitrate dehydrogenase (IDH1) to 2q33.3.

Authors:  K Narahara; S Kimura; K Kikkawa; Y Takahashi; Y Wakita; R Kasai; S Nagai; Y Nishibayashi; H Kimoto
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

3.  Duplication 2 (q11.2-q21): a previously unreported abnormality.

Authors:  L B Cooke; H Richards; P W Lunt; L Burvill-Holmes; R T Howell; A McDermott
Journal:  J Med Genet       Date:  1995-10       Impact factor: 6.318

4.  Mouse and hamster mutants as models for Waardenburg syndromes in humans.

Authors:  J H Asher; T B Friedman
Journal:  J Med Genet       Date:  1990-10       Impact factor: 6.318

5.  Pure monosomy and trisomy 2q24.2----q3105 due to an inv ins(7;2)(q21.2;q3105q24.2) segregating in four generations.

Authors:  M Moller; D García-Cruz; H Rivera; J Sánchez-Corona; J M Cantú
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.